Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry

CONCLUSION: RT can be omitted in patients with IRS I eRMS. RT improves LCS and EFS in IRS II and III. RT improves OS in patients with HN-PM, with proton RT comparable with photon RT. Doses of 32 Gy (HART) or 36 and 41.4 Gy (CFRT) had comparable efficacy in patients with favorable risk profiles and 44.8 Gy (HART) or 50.4 and 55.8 Gy (CFRT) in the unfavorable groups.PMID:37725766 | DOI:10.1200/JCO.22.02673

Source: Cancer Control - September 19, 2023 Category: Cancer & Oncology Authors: Ewa Koscielniak Beate Timmermann Marc M ünter Jadwiga Weclawek-Tompol Ruth Ladenstein Felix Niggli Gustaf Ljungman Ines B Brecht Bernd Blank Erika Hallmen Monika Scheer Joerg Fuchs Guido Seitz Claudia Blattmann Monika Sparber-Sauer Thomas Klingebiel Source Type: research